Literature DB >> 14205290

OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER.

B H PERSSON, L RISHOLM.   

Abstract

Entities:  

Keywords:  17-HYDROXYCORTICOSTEROIDS; BREAST NEOPLASMS; CASTRATION; CORTISONE, THERAPEUTIC; ESTRADIOL; ESTRIOL; ESTROGENS; ESTRONE; GERIATRICS; MENOPAUSE; NEOPLASM THERAPY; OVARY; URINE

Mesh：

Substances：

Year:  1964        PMID： 14205290     DOI： 10.1530/acta.0.0470015

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  5 in total

1.  A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

Authors:  G Ursin; S London; F Z Stanczyk; E Gentzschein; A Paganini-Hill; R K Ross; M C Pike
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

2.  A prospective study of urinary oestrogen excretion and breast cancer risk.

Authors:  T J Key; D Y Wang; J B Brown; C Hermon; D S Allen; J W Moore; R D Bulbrook; I S Fentiman; M C Pike
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

3.  Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.

Authors:  L Bernstein; R K Ross; M C Pike; J B Brown; B E Henderson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

4.  Serum oestradiol-17 beta in normal women.

Authors:  P C England; L G Skinner; K M Cottrell; R A Sellwood
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640

5.  Serum oestradiol-17 beta in women with benign and malignant breast disease.

Authors:  P C England; L G Skinner; K M Cottrell; R A Sellwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.